The Surge After the Surge: Cardiac Surgery Post-COVID-19

Rawn Salenger1, Eric W Etchill2, Niv Ad3

  • 1Division of Cardiac Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland.

Insights

Clearing the cardiac surgery backlog from COVID-19 requires significantly increased hospital operating capacity. Without enhanced capacity, the backlog of deferred surgeries may never be addressed, risking patient health outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Public Health
  • Health Systems Management

Background:

  • The COVID-19 pandemic led to substantial reductions in adult cardiac surgery case volumes.
  • Non-urgent cardiac procedures were postponed, creating a growing backlog of deferred cases.
  • A critical need exists to address this backlog efficiently once pandemic restrictions ease.

Purpose of the Study:

  • To investigate the impact of varying levels of increased hospital operating capacity on clearing the backlog of deferred adult cardiac surgery cases.
  • To model the time required to eliminate the surgical backlog under different post-pandemic capacity scenarios.

Main Methods:

  • Data were collected from 4 cardiac surgery programs across 2 health systems.
  • Baseline and pandemic-period case rates were recorded.
  • A mathematical model was developed to quantify the cumulative surgical backlog and predict backlog clearance time based on projected pandemic duration and increased operating capacity.

Main Results:

  • Cardiac surgery volumes decreased to 54% of baseline levels during the pandemic.
  • Clearing the backlog in one month would require 216%–263% of baseline monthly volume, depending on service restoration timing.
  • The time to clear the backlog ranged from 1 to 8 months, contingent on post-COVID hospital capacity and service restoration dates.

Conclusions:

  • Post-pandemic cardiac surgical operating capacity is a critical determinant of backlog clearance time.
  • Insufficient operating capacity can lead to significant delays, potentially increasing patient morbidity and mortality.
  • Restoring only pre-pandemic operating capacity is insufficient to clear the accumulated backlog of deferred cardiac surgeries.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
199
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
300
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
164
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
278
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
335